Education
About Us
Working with TipRanks
Follow Us
TScan Therapeutics (TCRX)
NASDAQ:TCRX
TScan Therapeutics (TCRX) Ownership Overview
20.20% Insiders
6.46% Mutual Funds
43.85% Other Institutional Investors
5.62% ETFs
23.87% Public Companies and Individual Investors
The ownership structure of TScan Therapeutics (TCRX) stock is a mix of institutional, retail, and individual investors. Approximately 55.93% of the company’s stock is owned by Institutional Investors, 20.20% is owned by Insiders, and 23.87% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 21, 2025 | xxxxxxxxxxxxx | $3106553 | |
Dec 16, 2024 | xxxxxxxxxxxxx | $385400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,946,141 | Insider | 15.14% | 8,740,755 | |
| 2,784,792 | Institution | 5.31% | 3,063,271 | |
| 2,528,583 | Insider | 4.82% | 2,781,441 | |
| 2,076,476 | Institution | 3.96% | 2,284,124 | |
| 1,954,611 | Institution | 3.73% | 2,150,072 | |
| 598,220 | Institution | 1.14% | 658,042 | |
| 528,372 | Institution | 1.01% | 581,209 | |
| 470,068 | Institution | 0.90% | 517,075 | |
| 456,608 | Institution | 0.87% | 502,269 | |
| 143,700 | Institution | 0.27% | 158,070 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,076,476 | Institution | 3.96% | 2,284,124 | |
| 598,220 | Institution | 1.14% | 658,042 | |
| 470,068 | Institution | 0.90% | 517,075 | |
| 143,700 | Institution | 0.27% | 158,070 | |
| 29,605 | Institution | 0.06% | 32,566 | |
| 27,590 | Institution | 0.05% | 30,349 | |
| 22,104 | Institution | 0.04% | 24,314 | |
| 13,109 | Institution | 0.02% | 14,420 | |
| 4,279 | Institution | <0.01% | 4,707 | |
| 1,462 | Institution | <0.01% | 1,608 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,377,026 | Institution | 2.62% | 2,506,187 | |
| 577,585 | Institution | 1.10% | 1,051,205 | |
| 528,372 | Institution | 1.01% | 597,060 | |
| 299,768 | Institution | 0.57% | 329,745 | |
| 103,066 | Institution | 0.20% | 116,465 | |
| 30,191 | Institution | 0.06% | 34,116 | |
| 3,821 | Institution | <0.01% | 4,318 | |
| 2,792 | Institution | <0.01% | 3,155 | |
| 2,082 | Institution | <0.01% | 2,290 |
FAQ
Who Owns TScan Therapeutics (TCRX)?
According to the latest TipRanks data, approximately 43.85% of the company's stock is held by institutional investors, 20.20% is held by insiders, and 23.87% is held by retail investors.
What percentage of TScan Therapeutics (TCRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.85% of TScan Therapeutics (TCRX) stock is held by institutional investors.
What percentage of TScan Therapeutics (TCRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.87% of TScan Therapeutics (TCRX) stock is held by retail investors.
Who owns the most shares of TScan Therapeutics (TCRX)?
Lynx1 Capital Management LP owns the most shares of TScan Therapeutics (TCRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.